openPR Logo
Press release

Point-of-care Diagnostic Products and Devices- Market Size and Forecast Analysis 2016-2020

01-24-2017 11:11 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: SA-BRC

Point-of-care Diagnostic Products and Devices- Market Size

Point-of-care diagnosis is performed at patient?s bed-side which usually is away from formal healthcare setting. For improving the outcome of medical care, it is extremely important for the physician to have more and more information about patient?s current status. Extended time lag for treatment initiation may also lead to serious complications. Point-of-care technologies have been vital in providing rapid test results, and reducing treatment time and cost. An important aspect of point-of-care diagnostic devices is that these devices are simple enough to be used by non-professionals, and under non-laboratory setting. These factors have positioned the point-of-care diagnostic products and devices as an indispensible part of emergency care services. As point-of-care devices do not require formal laboratory setting, and are easy to use, they are also widely used for at-home disease testing.

The global point-of-care diagnostic products and devices market can be broadly segmented as below:

Point-of-care products and devices, by indication:
Diabetes testing
Cardiac testing
Cancer testing
Infectious disease testing
Blood testing
Pregnancy testing

Point-of-care products and devices, by prescription:
Over-the-counter products and devices
Prescription only products and devices

Free Sample Report@

Point-of-care technologies have touched almost every aspect of healthcare with applications in varied medical fields such as cancer, diabetes, cardiovascular disorders, infectious diseases, blood disorders, pregnancy and others. Due to its wide scope, large numbers of multinational companies are competing intensely in the global market place. In 2014, Becton Dickinson and Company strengthened its point-of-care business segment with the acquisition of Alverix. Roche acquired IQuum, Inc. to gain access to the patented Laboratory-in-a-tube (Liat) System. Later in 2016, a major deal in point-of-care market was signed by Abbott for acquisition of Alere, which would make the company a leading player in point-of-care testing market. Currently Alere is the leading players in cardiac and infectious testing segments in point-of-care market.

Rigorous research and development in the medical field has given vital insights to newer markers involved in complex biochemical pathways leading to serious disorders. This deeper understanding of disease progression, coupled with advanced electronic technology has resulted to evolution of point-of-care diagnostic devices. Rising disease prevalence and need for bed-side medical assistance are other factors driving the market.

Diabetes testing accounts for more than 55% share in the point-of-care diagnostic products and devices market. This segmented is also expected to grow at a rate of more than 8% in the near future. According to World Health Organization (WHO) over 422 million individuals were recorded having diabetes in 2014 globally.

Click For Request TOC@

Abbott Laboratories, Inc,Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc.,Becton, Dickinson and Company, Johnson & Johnson, Instrumentation Laboratory, PTS Diagnostics, and Nova Biomedical are some of the key players in the point-of-care diagnostic products and devices market.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Point-of-care Diagnostic Products and Devices- Market Size and Forecast Analysis 2016-2020 here

News-ID: 420451 • Views: 182

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases

More Releases for Device

Walking Assist Device
The Walking Assist Device Market 2018 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Walking Assist Devicese industry. First, " Walking Assist Devicese Industry 2018" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Walking Assist Devicese industry chain structure. Walking Assist Device Market Top Players Honda Motor Co., Ltd., Permobil
Molded Interconnect Device Market
Molded Interconnect Device Market-Global Industry Analysis and Forecast (2018-2026) by Process, Product Type, End-user application and geography Molded Interconnect Device Market was valued US$ 300 Mn in 2017 and is expected to reach US$ 890.5 Mn by 2026 at a CAGR of 14.57% during forecast period. Molded Interconnect Device market is segmented by process, product, end-user application and region. Increasing demand in electrical and mechanical application, rising use of Molded Interconnect Device
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in
Timing Device Market
Asia Pacific traffic sensor market is expected to hold the majority share due to the adoption of technologically-advanced systems. Growing urban population and the increasing need for real-time information systems in the region will propel the traffic sensor market growth. Growing urban population in countries including India, China, Japan, and South Korea is increasing the strain on the traffic management solutions. This is encouraging the governments to invest increasingly in
Neurorehabilitation Devices - MIME Robotic Device
Bioness Inc., Bionik Laboratories Corp., Bioxtreme, Denecor, Ectron Ltd., Ekso Bionics, Helius Medical Technologies, Hocoma AG, MagVenture A/S, Medtronic, Neuro Style, Rehab-Robotics Company Limited, Rehabtronics Inc, St Jude Medical Inc., Tyromotion are some of the prominent players at the forefront of competition in the global Neurorehabilitation Devices Market and are profiled in MRFR Analysis. Global Neurorehabilitation Devices Market - Overview The neurorehabilitation devices market is growing with the rapid pace. According
Global Medical Device Connectivity Market
Global Medical Device Connectivity Market, By Type (Integration Software, Connectivity Hardware (Wired, Wireless (Wi-Fi, WMTS, Bluetooth), By Applications (Electronic Medical Record, Patient Monitoring, Others), By End-User (Hospitals, Community Healthcare, Clinics, Others), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2024 The Global Medical Device Connectivity Market has accounted for USD 5.7 billion in 2016 and is expected to reach